Live! #36 — Types of EU MDR Clinical Evidence Gaps and Best Practice Solutions - Part 2! - podcast episode cover

Live! #36 — Types of EU MDR Clinical Evidence Gaps and Best Practice Solutions - Part 2!

Jun 03, 202143 minTranscript available on Metacast
--:--
--:--
Listen in podcast apps:

Episode description

This is the audio-only version of RQM+ Live! #36, originally recorded June 3, 2021.

We're back for part two! With so many questions we couldn't address during our April 22, 2021 show on this topic (available on demand), we needed to come back a second time. This is clearly a topic many of you are interested in and we want to help, so here's a second chance to learn from RQM+ subject matter experts who are solving clinical evidence challenges for our clients every day.

"Insufficient clinical evidence" is the most popular and arguably the most difficult notified body deficiency to address. This finding comes in many shapes and sizes, as do the possible solutions. In this Live! episode, our panel of experts will discuss the following and more:

  • What types of clinical evidence gaps are notified bodies citing?
  • What are some solutions to enable keeping your devices on the market?
  • What's the best approach to documenting clinical evidence weaknesses in your technical documentation, to improve your odds of notified body acceptance?
  • How do you leverage your PMCF plan as a mitigation for clinical data weakness?
  • How do you make all of the documentation sing together - CER, PMCF plan, SSCP, Risk file, labeling - providing a cohesive clinical evidence story to the notified body that they can feel good about approving?

Our panel includes Amie Smirthwaite, former Head of BSI Global Clinical, and Jai Kutty, just months out of BSI, along with RQM+ subject matter experts who are solving clinical evidence challenges for our clients every day!

  • Amie Smirthwaite, Ph.D. - Global VP, Clinical Regulatory Services
  • Jaishankar (Jai) Kutty, Ph.D. - VP, Clinical Regulatory Services
  • Jon Gimbel, Ph.D. - Executive Director, Regulatory and Quality Consulting Services
  • Sally Sennitt, MBBS, FRCA - Medical Director

-

About RQM+

RQM+ is the world's leading medical device and diagnostics focused regulatory and quality consulting firm. We deliver transformative solutions by providing an unrivaled collective expertise, fueled by passion for client success. Our experts are collaborative, laser-focused on client needs, and committed to delivering high value solutions that exceed expectations. Learn more at RQMplus.com.